AS 2553627( AS2553627 | AS-2553627 )

Catalog No. M11009 CAS No. 1251906-07-6

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

AS 2553627
Note

Research use only, not for human use.
Brief Description

AS 2553627 (AS2553627) is a novel potent, selective pan-JAK inhibitor.
Description

AS 2553627 (AS2553627) is a novel potent, selective pan-JAK inhibitor with IC50 of 0.46, 0.30, 0.14 and 2.0 nM for JAK1, JAK2, JAK3 and TYK2, respectively; displays no inhibitory activity against a panel of protein kinases, including SYK and ZAP70 at 1 uM; inhibits proliferation of IL-2 stimulated human and rat T cells with IC50 of 2.4 and 4.3 nM, respectively, inhibits the proliferation of TF-1 cells stimulated with EPO with IC50 of 12 nM; effectively prevents chronic rejection in rat cardiac allografts in rat cardiac transplant model alone or co-administration with tacrolimus.
In Vitro

——
In Vivo

——
Synonyms

AS2553627 | AS-2553627
Pathway

Angiogenesis
Target

JAK
Recptor

JAK
Research Area

——
Indication

——

CAS Number

1251906-07-6
Formula Weight

321.384
Molecular Formula

C18H19N5O
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

3-((3R,4R)-3-(dipyrrolo[2,3-b:2',3'-d]pyridin-1(6H)-yl)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

1. Nakamura K, et al. Eur J Pharmacol. 2017 Feb 5;796:69-75. 2. Nakamura K, et al. Transpl Immunol. 2017 Oct 5. pii: S0966-3274(17)30038-2.

Calculator

molnova catalog